Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nurix Therapeutics (NRIX) Return on Assets (2020 - 2025)

Nurix Therapeutics (NRIX) has disclosed Return on Assets for 6 consecutive years, with 0.44% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 11.0% to 0.44% in Q4 2025 year-over-year; TTM through Nov 2025 was 0.44%, a 11.0% decrease, with the full-year FY2025 number at 0.39%, down 1.0% from a year prior.
  • Return on Assets was 0.44% for Q4 2025 at Nurix Therapeutics, up from 0.44% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.19% in Q1 2021 to a low of 0.45% in Q1 2023.
  • A 5-year average of 0.36% and a median of 0.39% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -20bps in 2022, then increased 11bps in 2024.
  • Nurix Therapeutics' Return on Assets stood at 0.24% in 2021, then tumbled by -70bps to 0.41% in 2022, then fell by -5bps to 0.43% in 2023, then rose by 25bps to 0.33% in 2024, then crashed by -33bps to 0.44% in 2025.
  • Per Business Quant, the three most recent readings for NRIX's Return on Assets are 0.44% (Q4 2025), 0.44% (Q3 2025), and 0.34% (Q2 2025).